Harvey E. Behrend

Array ( [id] => 4208693 [patent_doc_number] => 06028105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Topical drug delivery composition and method' [patent_app_type] => 1 [patent_app_number] => 8/484548 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3530 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028105.pdf [firstpage_image] =>[orig_patent_app_number] => 484548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3628672 [patent_doc_number] => 05686448 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Treatment of virus infections with ganglionic blocking agents' [patent_app_type] => 1 [patent_app_number] => 8/483965 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10857 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686448.pdf [firstpage_image] =>[orig_patent_app_number] => 483965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658775 [patent_doc_number] => 05627166 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Activator for acaracide' [patent_app_type] => 1 [patent_app_number] => 8/478266 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2466 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627166.pdf [firstpage_image] =>[orig_patent_app_number] => 478266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3702609 [patent_doc_number] => 05674869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Pharmaceutical treatment' [patent_app_type] => 1 [patent_app_number] => 8/469273 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2178 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674869.pdf [firstpage_image] =>[orig_patent_app_number] => 469273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657959 [patent_doc_number] => 05658912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Apoptosis regulating composition' [patent_app_type] => 1 [patent_app_number] => 8/469922 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 25 [patent_no_of_words] => 11252 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658912.pdf [firstpage_image] =>[orig_patent_app_number] => 469922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626005 [patent_doc_number] => 05620983 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions' [patent_app_type] => 1 [patent_app_number] => 8/470103 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8577 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620983.pdf [firstpage_image] =>[orig_patent_app_number] => 470103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3895926 [patent_doc_number] => 05750529 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Apoptosis regulating compostion' [patent_app_type] => 1 [patent_app_number] => 8/469505 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 25 [patent_no_of_words] => 11256 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750529.pdf [firstpage_image] =>[orig_patent_app_number] => 469505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3723891 [patent_doc_number] => 05672603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Apoptosis regulating composition' [patent_app_type] => 1 [patent_app_number] => 8/466449 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 25 [patent_no_of_words] => 11237 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672603.pdf [firstpage_image] =>[orig_patent_app_number] => 466449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3555660 [patent_doc_number] => 05543412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Hepatitis treatment with carbostyril compounds' [patent_app_type] => 1 [patent_app_number] => 8/469893 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 25 [patent_no_of_words] => 11310 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543412.pdf [firstpage_image] =>[orig_patent_app_number] => 469893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575237 [patent_doc_number] => 06469015 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Pharmaceutical formulation' [patent_app_type] => B1 [patent_app_number] => 08/462257 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3018 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469015.pdf [firstpage_image] =>[orig_patent_app_number] => 08462257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689228 [patent_doc_number] => 05691350 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Use of linomide for treatment of retrovirus infections specifically HIV infections' [patent_app_type] => 1 [patent_app_number] => 8/462050 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 13 [patent_no_of_words] => 2999 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691350.pdf [firstpage_image] =>[orig_patent_app_number] => 462050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103841 [patent_doc_number] => 06100277 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Retroviral protease inhibitor combinations' [patent_app_type] => 1 [patent_app_number] => 8/458154 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14389 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100277.pdf [firstpage_image] =>[orig_patent_app_number] => 458154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686839 [patent_doc_number] => 05663169 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Benzoxazinones as inhibitors of HIV reverse transcriptase' [patent_app_type] => 1 [patent_app_number] => 8/458528 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11012 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663169.pdf [firstpage_image] =>[orig_patent_app_number] => 458528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235450 [patent_doc_number] => 06075024 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Methods for treating infection using optically pure (S)-lomefloxacin' [patent_app_type] => 1 [patent_app_number] => 8/455471 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5782 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075024.pdf [firstpage_image] =>[orig_patent_app_number] => 455471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624183 [patent_doc_number] => 05602172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Methods of inhibiting Pneumocystis carinii pneumonia, Giardia lamblia, and Cryptosporidium and compounds useful therefor' [patent_app_type] => 1 [patent_app_number] => 8/453276 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13476 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602172.pdf [firstpage_image] =>[orig_patent_app_number] => 453276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623923 [patent_doc_number] => 05612322 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Activator for herbicide' [patent_app_type] => 1 [patent_app_number] => 8/451187 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2471 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612322.pdf [firstpage_image] =>[orig_patent_app_number] => 451187 [rel_patent_id] =>[rel_patent_doc_number] =>)